Literature DB >> 22581580

The face signature of fibrodysplasia ossificans progressiva.

Peter Hammond1, Michael Suttie, Raoul C Hennekam, Judith Allanson, Eileen M Shore, Frederick S Kaplan.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) causes extensive heterotopic bone formation due to heterozygous mutations in the glycine-serine activation domain of ACVR1 (ALK2), a bone morphogenetic protein type I receptor. Anecdotal observations of facial similarity have been made by clinicians and parents, but no objective quantitative analysis of the faces of FOP patients has ever been undertaken. We delineated the common facial characteristics of 55 individuals with molecularly confirmed FOP by analyzing their face signature (face shape difference normalized against age and sex matched controls) and associated face signature graphs (with face signatures as vertices and adjacency corresponding to greatest similarity). Our analysis identified 10 affected individuals whose face signature is more homogeneous than others with FOP. This distinct subgroup showed the previously identified reduced mandible as well as newly identified features: underdevelopment of the upper orbit/supra-orbital ridge; infra-orbital prominence; and, low-set ears. These findings strongly suggest that the canonical FOP mutation variably affects the postnatal morphogenesis of the normotopic cranial skeleton in the upper midface and mandible and may have important diagnostic and functional implications.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22581580      PMCID: PMC3356438          DOI: 10.1002/ajmg.a.35346

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  32 in total

1.  Estimating average growth trajectories in shape-space using kernel smoothing.

Authors:  Tim J Hutton; Bernard F Buxton; Peter Hammond; Henry W W Potts
Journal:  IEEE Trans Med Imaging       Date:  2003-06       Impact factor: 10.048

2.  Discriminating power of localized three-dimensional facial morphology.

Authors:  Peter Hammond; Tim J Hutton; Judith E Allanson; Bernard Buxton; Linda E Campbell; Jill Clayton-Smith; Dian Donnai; Annette Karmiloff-Smith; Kay Metcalfe; Kieran C Murphy; Michael Patton; Barbara Pober; Katrina Prescott; Pete Scambler; Adam Shaw; Ann C M Smith; Angela F Stevens; I Karen Temple; Raoul Hennekam; May Tassabehji
Journal:  Am J Hum Genet       Date:  2005-10-26       Impact factor: 11.025

3.  GTF2IRD1 in craniofacial development of humans and mice.

Authors:  May Tassabehji; Peter Hammond; Annette Karmiloff-Smith; Pamela Thompson; Snorri S Thorgeirsson; Marian E Durkin; Nicholas C Popescu; Timothy Hutton; Kay Metcalfe; Agnes Rucka; Helen Stewart; Andrew P Read; Mark Maconochie; Dian Donnai
Journal:  Science       Date:  2005-11-03       Impact factor: 47.728

4.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

5.  Abnormal temporomandibular joints in fibrodysplasia ossificans progressiva.

Authors:  P Renton; S F Parkin; T C Stamp
Journal:  Br J Oral Surg       Date:  1982-03

6.  The BMP antagonists Chordin and Noggin have essential but redundant roles in mouse mandibular outgrowth.

Authors:  R W Stottmann; R M Anderson; J Klingensmith
Journal:  Dev Biol       Date:  2001-12-15       Impact factor: 3.582

7.  Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.

Authors:  A B Shafritz; E M Shore; F H Gannon; M A Zasloff; R Taub; M Muenke; F S Kaplan
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

8.  Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva.

Authors:  W Luchetti; R B Cohen; G V Hahn; D M Rocke; M Helpin; M Zasloff; F S Kaplan
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1996-01

9.  3D analysis of facial morphology.

Authors:  Peter Hammond; Tim J Hutton; Judith E Allanson; Linda E Campbell; Raoul C M Hennekam; Sean Holden; Michael A Patton; Adam Shaw; I Karen Temple; Matthew Trotter; Kieran C Murphy; Robin M Winter
Journal:  Am J Med Genet A       Date:  2004-05-01       Impact factor: 2.802

10.  Submandibular swelling in patients with fibrodysplasia ossificans progressiva.

Authors:  H B Janoff; M A Zasloff; F S Kaplan
Journal:  Otolaryngol Head Neck Surg       Date:  1996-04       Impact factor: 5.591

View more
  19 in total

1.  Facial dysmorphism across the fetal alcohol spectrum.

Authors:  Michael Suttie; Tatiana Foroud; Leah Wetherill; Joseph L Jacobson; Christopher D Molteno; Ernesta M Meintjes; H Eugene Hoyme; Nathaniel Khaole; Luther K Robinson; Edward P Riley; Sandra W Jacobson; Peter Hammond
Journal:  Pediatrics       Date:  2013-02-25       Impact factor: 7.124

Review 2.  Large-scale objective phenotyping of 3D facial morphology.

Authors:  Peter Hammond; Michael Suttie
Journal:  Hum Mutat       Date:  2012-03-20       Impact factor: 4.878

3.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

Review 4.  Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation.

Authors:  Irina Hüning; Gabriele Gillessen-Kaesbach
Journal:  Mol Syndromol       Date:  2014-08-07

5.  Facial Curvature Detects and Explicates Ethnic Differences in Effects of Prenatal Alcohol Exposure.

Authors:  Michael Suttie; Leah Wetherill; Sandra W Jacobson; Joseph L Jacobson; H Eugene Hoyme; Elizabeth R Sowell; Claire Coles; Jeffrey R Wozniak; Edward P Riley; Kenneth L Jones; Tatiana Foroud; Peter Hammond
Journal:  Alcohol Clin Exp Res       Date:  2017-07-10       Impact factor: 3.455

6.  The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development.

Authors:  Diana Rigueur; Sean Brugger; Teni Anbarchian; Jong Kil Kim; YooJin Lee; Karen M Lyons
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

Review 7.  Cellular and morphological aspects of fibrodysplasia ossificans progressiva. Lessons of formation, repair, and bone bioengineering.

Authors:  Anderson Martelli; Arnaldo Rodrigues Santos
Journal:  Organogenesis       Date:  2014-10-31       Impact factor: 2.500

8.  Craniofacial characteristics of fragile X syndrome in mouse and man.

Authors:  Inge Heulens; Michael Suttie; Andrei Postnov; Nora De Clerck; Concetta S Perrotta; Teresa Mattina; Francesca Faravelli; Francesca Forzano; R Frank Kooy; Peter Hammond
Journal:  Eur J Hum Genet       Date:  2012-12-05       Impact factor: 4.246

9.  Combined Face-Brain Morphology and Associated Neurocognitive Correlates in Fetal Alcohol Spectrum Disorders.

Authors:  Michael Suttie; Jeffrey R Wozniak; Scott E Parnell; Leah Wetherill; Sarah N Mattson; Elizabeth R Sowell; Eric Kan; Edward P Riley; Kenneth L Jones; Claire Coles; Tatiana Foroud; Peter Hammond
Journal:  Alcohol Clin Exp Res       Date:  2018-07-20       Impact factor: 3.455

Review 10.  The case for open science: rare diseases.

Authors:  Yaffa R Rubinstein; Peter N Robinson; William A Gahl; Paul Avillach; Gareth Baynam; Helene Cederroth; Rebecca M Goodwin; Stephen C Groft; Mats G Hansson; Nomi L Harris; Vojtech Huser; Deborah Mascalzoni; Julie A McMurry; Matthew Might; Christoffer Nellaker; Barend Mons; Dina N Paltoo; Jonathan Pevsner; Manuel Posada; Alison P Rockett-Frase; Marco Roos; Tamar B Rubinstein; Domenica Taruscio; Esther van Enckevort; Melissa A Haendel
Journal:  JAMIA Open       Date:  2020-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.